Clinical Trial

Neuroimage-guided Dual-target Continuous Theta Burst Stimulation for Generalized Anxiety Disorder

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical trial was to determine whether image-guided dual-target cTBS is effective for anxiety disorders. The main questions it aims to answer are: 1. Does dual-target cTBS improve patients' anxiety symptoms? 2. Does dual-target cTBS improve patients' somatization symptoms? 3. Researchers will compare cTBS real and sham stimulation to determine whether cTBS is effective in treating anxiety disorders. Participants will: 1. Received either cTBS treatment or sham stimulation for 7 consecutive days 2. Psychological assessment and MRI scan were performed before treatment, within 2 days, 2 weeks and 1 month after treatment 3. Adverse reactions during the experiment were recorded
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-19.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-08-17
Trial Details
NCT Number NCT06699706
Lead Sponsor Anhui Medical University
Conditions Anxiety, Transcranial Magnetic Stimulation Repetitive
Enrollment 60 participants
Start Date 2024-11-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-22